We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+12.54%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$567M
AUM Growth
+$327M
Cap. Flow
+$292M
Cap. Flow %
51.47%
Top 10 Hldgs %
88.03%
Holding
104
New
29
Increased
3
Reduced
10
Closed
60

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$111M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$111M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$69.4M
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$51.6M
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$37.4M

Top Sells

Rank Stock Value
1
GPCR icon
Structure Therapeutics
GPCR
+$25.3M
2
ARM icon
Arm
ARM
+$11.8M
3
STX icon
Seagate
STX
+$7.58M
4
ALIT icon
Alight
ALIT
+$6.79M
5
CART icon
Maplebear
CART
+$6.07M

Sector Composition

Rank Sector Weight
1 Healthcare 9.08%
2 Utilities 1.25%
3 Industrials 1.19%
4 Energy 0.8%
5 Financials 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNTK icon
26
Kinetik
KNTK
$7.98B
$2.17M 0.38%
+64,900
New +$2.27M
KVYO icon
27
Klaviyo
KVYO
$4.73B
$1.92M 0.34%
68,974
-91,766
-57% -$2.72M
AURA icon
28
Aura Biosciences
AURA
$826M
$1.76M 0.31%
+198,415
New +$1.68M
HCI icon
29
HCI Group
HCI
$2.41B
$1.73M 0.31%
+19,790
New +$1.45M
CRBG icon
30
Corebridge Financial
CRBG
$15B
$1.62M 0.29%
+75,000
New +$1.55M
ETNB
31
DELISTED
89bio
ETNB
$1.56M 0.28%
+140,000
New +$1.29M
RWAY icon
32
Runway Growth Finance
RWAY
$287M
$1.16M 0.2%
+91,739
New +$1.15M
ALPN
33
DELISTED
Alpine Immune Sciences Inc
ALPN
$964K 0.17%
+74,792
New +$1.04M
MYGN icon
34
Myriad Genetics
MYGN
$312M
$957K 0.17%
+50,000
New +$865K
CMPX icon
35
Compass Therapeutics
CMPX
$387M
$780K 0.14%
500,000
-726,142
-59% -$1.26M
STTK icon
36
Shattuck Labs
STTK
$694M
$713K 0.13%
+100,000
New +$273K
ANTX icon
37
AN2 Therapeutics
ANTX
$214M
$697K 0.12%
33,997
-65,498
-66% -$1.1M
BLUE
38
DELISTED
bluebird bio
BLUE
$690K 0.12%
+25,000
New +$1.52M
WVE icon
39
Wave Life Sciences
WVE
$1.2B
$522K 0.09%
+103,300
New +$552K
MTEM
40
DELISTED
Molecular Templates, Inc.
MTEM
$454K 0.08%
121,841
-20,000
-14% -$105K
CDTX
41
DELISTED
Cidara Therapeutics
CDTX
$293K 0.05%
18,455
– –
SEAT icon
42
Vivid Seats
SEAT
$85.4M
$190K 0.03%
1,500
-1,000
-40% -$137K
PCT icon
43
PureCycle Technologies
PCT
$1.45B
$47.6K 0.01%
11,754
– –
KPTI icon
44
Karyopharm Therapeutics
KPTI
$48M
$34.9K 0.01%
+8,829
New +$119K
AESI icon
45
Atlas Energy Solutions
AESI
$1.41B
– –
-72,499
Closed -$1.61M
ALIT icon
46
Alight
ALIT
$407M
– –
-47,894
Closed -$6.79M
AMKR icon
47
Amkor Technology
AMKR
$13.7B
– –
-75,000
Closed -$1.7M
AMPH icon
48
Amphastar Pharmaceuticals
AMPH
$916M
– –
-39,461
Closed -$1.81M
APO.PRA
49
DELISTED
Apollo Global Management Series A
APO.PRA
– –
-17,050
Closed -$939K
ARM icon
50
Arm
ARM
$302B
– –
-221,325
Closed -$11.8M
1
2
3 4

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Monashee Investment Management held 104 positions worth $567M, up 137% from $239M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Monashee Investment Management deployed $292M of net new capital in Q4 2023, opening 29 new positions and adding to 3 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 248,710 shares worth $119M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 32% a quarter earlier, followed by Utilities and Industrials.

On the sell side, the largest reduction was Structure Therapeutics, an estimated $25.3M trimmed.

  • Monashee Investment Management's largest Q4 2023 buy was iShares Core S&P 500 ETF: 248,710 shares worth $119M.
  • Monashee Investment Management added most to AerCap in Q4 2023, an estimated $1.98M increase.
  • Monashee Investment Management's biggest Q4 2023 reduction was Structure Therapeutics, cutting an estimated $25.3M.
  • Monashee Investment Management fully exited Arm in Q4 2023, selling an estimated $11.8M.
  • Monashee Investment Management's ten largest holdings make up 88% of its $567M portfolio in Q4 2023.
  • Monashee Investment Management opened 29 new positions and closed 60 in Q4 2023.
  • Monashee Investment Management's portfolio value rose 137% quarter-over-quarter to $567M.

Based on Monashee Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.